Evidence map›Paper›PMID 38344864›Full record

ArticleBriefings in bioinformatics2024

PB-LKS: a python package for predicting phage-bacteria interaction through local K-mer strategy.

Jingxuan Qiu, Wanchun Nie, Hao Ding, Jia Dai, Yiwen Wei, Dezhi Li, Yuxi Zhang, Junting Xie, Xinxin Tian, Nannan Wu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jingxuan QiuSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Wanchun NieSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Hao DingInstitute of Clinical Science, Zhongshan Hospital, Shanghai Institute of Infectious Disease and Biosecurity, Intelligent Medicine Institute, Fudan University, Shanghai, 200032, China.
Jia DaiShanghai Institute of Phage, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China.
Yiwen WeiSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Dezhi LiSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Yuxi ZhangSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Junting XieSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Xinxin TianSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, China.
Nannan WuShanghai Institute of Phage, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, China.
Tianyi QiuInstitute of Clinical Science, Zhongshan Hospital, Shanghai Institute of Infectious Disease and Biosecurity, Intelligent Medicine Institute, Fudan University, Shanghai, 200032, China.ORCID 0000-0001-6897-3923
University of Shanghai for Science and Technology · CNFudan University · CNShanghai Public Health Clinical Center · CN

Funding

National Key Research and Development Program of China 2022YFF1101104National Natural Science Foundation of China 32000470Shanghai Commission of Science and Technology 20Y11900300
6 · The paper itself

Abstract

Bacteriophages can help the treatment of bacterial infections yet require in-silico models to deal with the great genetic diversity between phages and bacteria. Despite the tolerable prediction performance, the application scope of current approaches is limited to the prediction at the species level, which cannot accurately predict the relationship of phages across strain mutants. This has hindered the development of phage therapeutics based on the prediction of phage-bacteria relationships. In this paper, we present, PB-LKS, to predict the phage-bacteria interaction based on local K-mer strategy with higher performance and wider applicability. The utility of PB-LKS is rigorously validated through (i) large-scale historical screening, (ii) case study at the class level and (iii) in vitro simulation of bacterial antiphage resistance at the strain mutant level. The PB-LKS approach could outperform the current state-of-the-art methods and illustrate potential clinical utility in pre-optimized phage therapy design.

Indexed as

Bacterial InfectionsBacteriophagesBacteriaHumansbioinformaticsgenome sequence analysislocal K-mer strategymachine learningphage–bacteria interaction

Identifiers

PMID38344864
PMCPMC10859729
OpenAlexW4391766310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.